Fig. 4

Prognostic value of CYP27A1 in the different subgroups. The overall survival (A) and disease-specific survival (B) in all LUAD patients. The overall survival in LUAD patients for N0 stage (C), anatomic neoplasm subdivision (D), and male (E) subgroups